As workforce health and safety is vital to us, we’re taking every precautions to minimize the risk of spreading the COVID-19 infection and the presentation by Dr. Michael Tovey on the exciting topic: “Development of potency assays for the quantification of AAV encoded transgenes expressed under the control of retina specific promoters” is therefore planned to be live streamed for the conference.
In the meantime, book a free online consultation to speak to one of our scientific experts and find out how our cell-based solutions can help you plan for your drug development initiatives in 2020.
